Transluminal percutaneous septal myocardial ablation in a patient with hypertrophic obstructive cardiomyopathy

Japanese Circulation Journal

Volumn 62, Issue 7, 1998, Pages 537-540

  Tsuchikane, Etsuo ^a   Nakamura, Toshinori ^a   Yamazaki, Keita ^a   Kitano, Katsuya ^a   Izumi, Masahiro ^a   Otsuji, Satoru ^a   Tateyama, Hitone ^a   Awata, Nobuhisa ^a   Sakurai, Makoto ^a   Kobayashi, Tohru ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Hypertrophic obstructive cardiomyopathy; Percutaneous myocardial ablation; Septal infarction

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CATHETER ABLATION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; TREATMENT OUTCOME;

EID: 3142566840     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.537     Document Type: Article

References (18)

1. Flamm MD, Harrison DC, Hancock EW: Muscular subaortic stenosis: prevention of outflow obstruction with propranolol. Circulation 1968; 38: 846-858
2. Chatterjee K: Calcium antagonist agents in hypertrophic cardiomyopathy. Am J Cardiol 1987; 59: 146B-152B
3. Sherrid M, Delia E, Dwyer E: Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1988; 62: 1085-1088
4. McDonald K, McWilliams E, O'Keeffe B, Maurer B: Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment of hypertrophic cardiomyopathy. Eur Heart J 1988; 9: 893-899
5. Jeanrenaud X, Coy J-J, Kappenberger L: Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339: 1318-1323
6. McIntosh CL, Maron BJ: Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 1988; 78: 487-495
7. Seiler C, Hess OM, Schoenbeck M, Turina J, Jenni R, Turina M, et al: Long term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 1991; 17: 634-642
8. Mohr R, Schaff HV, Danielson GK, Puga FJ, Pluth JR, Tajik AJ: The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 1989; 97: 666-674
9. Sigwart U: Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211-214
10. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, et al: Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997; 95: 2075-2081
11. Ciro E, Nichols PF III, Maron BJ: Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 1983; 67: 1227-1233
12. Shimizu M, Ueyama T, Mohara O, Hano T, Ueno Y, Nishio I: A case of hypertrophic obstructive cardiomyopathy associated with autonomic nervous dysfunction. Jpn Circ J 1996; 60: 371-376
13. Maeda T, Ashie T, Kikuiri K, Fukuyama S, Yamaguchi Y, Yoshida E, et al: Fragmentation hemolysis in a patient with hypertrophic obstructive cardiomyopathy and mitral valve prolapse. Jpn Circ J 1992; 56: 970-974
14. Borer JS, Bacharach SL, Green MV, Kent KM, Rosing DR, Seides SF, et al: Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS. Circulation 1979; 60(Suppl I): I-82-I-87
15. Faber L, Seggewiss H, Fassbender D, Strick S, Bogunovic N, Gleichman U: Identification of the target vessel in percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography. Circulation 1997; 96 (Suppl I): I-639
16. Seggewiss H, Faber L, Gleichman U, Fassbender D, Schmidt HK, Strick S: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute hemodynamic and clinical results. Circulation 1997; 96 (Suppl I): I-218
17. Seggewiss H, Faber L, Gleichman U, Fassbender D, Strick S, Schmidt HK, et al: Mid-term follow-up results after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Circulation 1997; 96 (Suppl I): I-463
18. Kurbaan AS, Seggewiss H, Henein MY, Knight CJ, Sigwart U: Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: longer term follow-up of the early patients. Circulation 1997; 96 (Suppl I): I-463